Sp1 has been used as a control protein to compare with when studying the increase or decrease of the
aryl hydrocarbon receptor and/or the
estrogen receptor, since it binds to both and generally remains at a relatively constant level. Recently, a putative
promoter region in
FTMT, and positive regulators {SP1,
cAMP response element-binding protein (CREB), and Ying Yang 1 (
YY1)] and negative regulators [GATA2, forkhead box protein A1
(FoxA1), and CCAAT enhancer-binding protein b (C/EBPb)] of FTMT transcription have been identified (Guaraldo et al, 2016).The effect of DFP on the DNA-binding activity of these regulators to the FTMT promoter was examined using chromatin immunoprecipitation (ChIP) assay. Among the regulators, only SP1 displayed significantly increased DNA- binding activity following DFP treatment in a dose-dependent manner. SP1 knockdown by siRNA abolished the DFP-induced increase in the mRNA levels of FTMT, indicating SP1-mediated regulation of FTMT expression in the presence of DFP. Treatment with
Deferiprone increased the expression of cytoplasmic and nuclear SP1 with predominant localization in the nucleus. == Inhibitors ==